Combatting HIV, AIDS, TB and viral hepatitis in the EU


  • Mary Corcoran
  • Univadis Medical News
El acceso al contenido completo es sólo para profesionales sanitarios registrados. El acceso al contenido completo es sólo para profesionales sanitarios registrados.

As more than 15,000 delegates meet in Amsterdam this week to attend the 22nd International AIDS Conference (AIDS 2018), the European Commission has published a new staff working document on combatting HIV/AIDS, viral hepatitis and tuberculosis (TB). 

The document presents the current epidemiological situation for HIV/AIDS, viral hepatitis and tuberculosis in Europe. It details how in 2016, 29,444 cases of HIV were reported to the European Centre for Disease Prevention and Control (ECDC) from 31 European Union/European Economic Area (EU/EEA) Member States, corresponding to a crude rate of 5.9 new diagnoses per 100,000 population. Almost 59,000 cases of TB were reported for the same year. Meanwhile the document shows deaths from hepatitis B and C together now exceed deaths from HIV/AIDS and TB combined, with the latest estimates suggesting 96,000 people die each year in EU/EEA countries from hepatitis B virus (HBV) and hepatitis C virus (HCV)-related liver disease. 

The document also provides an overview of EU policy initiatives and activities to help Member States meet the global sustainable development goal of ending the AIDS and TB epidemics by 2030 and to fight hepatitis and other communicable diseases.